Innovation

Packets of the IT-Leish rapid diagnostic test (RDT) for visceral leishmaniasis are displayed against a gradient background transitioning from teal to purple. Each white packet is clearly labeled with identification details including "IT LEISH", lot numbers, and expiration dates, along with the IVD (in vitro diagnostic) symbol, emphasizing their use in medical diagnostics. The packets are partially overlapped, focusing on their essential information and sterile packaging.

GADx reintroduces IT LEISH, the rapid diagnostic test for visceral leishmaniasis

Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics, today announced the launch of IT LEISH, a rapid diagnostic test (RDT) for visceral leishmaniasis (VL). The company acquired the manufacturing rights for…

COVI-GO-1920w

COVID-19 Rapid Antigen Self-Test, COVI-Go™, receives FDA Emergency Use Authorization for home use

Mologic Inc., the US subsidiary of  Global Access Diagnostics (GADx), a leading developer of lateral flow and rapid diagnostic technologies, products and services, announced today that its proprietary COVI-Go™ SARS-CoV-2 Ag Self-Test received Emergency Use…

Detecting Multiple Diseases At Once: EU-Funded Didida Project Develops A Cost-Effective Mobile Based Solution In Africa

Detecting multiple diseases at once: EU-funded DIDIDA project develops a cost-effective mobile based solution in Africa

The Digital Innovations and Diagnostics for Infectious Diseases in Africa (DIDIDA) had its official kick-off at the Strathmore University. DIDIDA is an ambitious project to develop reliable, low-cost, mobile phone-connected tests to help detect multiple…

GADx formed to expand affordable access to advanced rapid diagnostic technologies

Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global health, today formally introduced its first portfolio company, Global Access Diagnostics (GADx). GADx has been created to address gaps in…